Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
antihemophilic factor viii (Recombinant), Fc-fusion protein (Eloctate) (1 trial)
bevacizumab (avastin) (1 trial)
calcium (1 trial)
coagulation factor viia (recombinant) (NovoSevenRT) (2 trials)
denosumab (prolia) (1 trial)
docetaxel (taxotere) (1 trial)
eptacog (Novoseven) (1 trial)
fluorouracil (efudex) (1 trial)
irinotecan (Camptosar) (1 trial)
leucovorin (1 trial)
trastuzumab (herceptin) (1 trial)
vitamin d3 (1 trial)
etanercept (enbrel) (1 trial)
Breast Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Factor VII Deficiency (Phase 3)
Hemophilia A (Phase 3)
Neoplasms (Phase 3)
Osteoporosis (Phase 3)
Trials (8 total)
Trial APIs (13 total)